Membranoproliferative glomerulonephritis: Difference between revisions
Nazia Fuad (talk | contribs) No edit summary |
No edit summary |
||
Line 21: | Line 21: | ||
}} | }} | ||
{{Membranoproliferative glomerulonephritis}} | {{Membranoproliferative glomerulonephritis}} | ||
{{CMG}} {{APM}}; '''Associate Editor-In-Chief:''' {{OO}}{{CZ}} {{N.F}} | {{CMG}} {{APM}}; '''Associate Editor-In-Chief:''' {{OO}}{{CZ}} {{N.F}}{{JSS}} | ||
== [[Membranoproliferative glomerulonephritis overview|Overview]] == | == [[Membranoproliferative glomerulonephritis overview|Overview]] == |
Revision as of 17:36, 30 July 2018
https://https://www.youtube.com/watch?v=uriIHhO5kVQ%7C350}} |
Membranoproliferative glomerulonephritis | |
ICD-10 | N00-N08 with .2 suffix |
---|---|
ICD-9 | 581.2, 582.2, 583.2 |
MeSH | D015432 |
Membranoproliferative glomerulonephritis Microchapters |
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Membranoproliferative glomerulonephritis On the Web |
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis |
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
Risk calculators and risk factors for Membranoproliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ali Poyan Mehr, M.D. [2]; Associate Editor-In-Chief: Olufunmilola Olubukola M.D.[3]Cafer Zorkun, M.D., Ph.D. [4] Nazia Fuad M.D. Jogeet Singh Sekhon, M.D. [5]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Membranoproliferative glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
| Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies